Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players
- PMID: 16541419
- DOI: 10.1002/pros.20421
Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players
Abstract
Background: As advanced prostate cancers are resistant to currently available chemotherapies, we evaluated the cytotoxic effect of TNF-related apoptosis-inducing ligand (TRAIL) and characterized the involvement of its five receptors DR4, DR5, DcR1, DcR2, and osteoprotegerin (OPG) and of the death-inducing signaling complex (DISC)-forming proteins caspase 8 and c-FLIP in prostate cell lines.
Methods: We used six prostate cell lines, each corresponding to a particular stage in prostate tumorigenesis, and analyzed TRAIL sensitivity in relation to TRAIL receptors' expression.
Results: TRAIL sensitivity was correlated with tumor progression and DR5 expression levels and apoptosis was exclusively mediated by DR5. DcR2 was significantly more abundant in tumor cells than in non-neoplastic ones and may contribute to partial resistance to TRAIL in some prostate tumor cells. Conversely, non-tumoral cells secreted high levels of OPG, which can protect them from apoptosis. Finally, caspase 8 expression levels were as DR5 directly correlated to TRAIL sensitivity in prostate tumor cells.
Conclusion: TRAIL-induced apoptosis is closely related to the balanced expression of its different receptors in prostate cancer cells and their modulation could be of potential clinical value for advanced tumor treatment.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
-
Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.Cancer Res. 2001 Mar 15;61(6):2704-12. Cancer Res. 2001. PMID: 11289151
-
Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.Cancer Res. 2001 Jan 15;61(2):759-63. Cancer Res. 2001. PMID: 11212279
-
Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.Prostate Cancer Prostatic Dis. 2005;8(3):274-9. doi: 10.1038/sj.pcan.4500798. Prostate Cancer Prostatic Dis. 2005. PMID: 15897917
-
Mechanisms of resistance to TRAIL-induced apoptosis in cancer.Cancer Gene Ther. 2005 Mar;12(3):228-37. doi: 10.1038/sj.cgt.7700792. Cancer Gene Ther. 2005. PMID: 15550937 Review.
-
Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.Vitam Horm. 2004;67:453-83. doi: 10.1016/S0083-6729(04)67023-3. Vitam Horm. 2004. PMID: 15110190 Review.
Cited by
-
Dihydrotestosterone Increases Cytotoxic Activity of Macrophages on Prostate Cancer Cells via TRAIL.Endocrinology. 2019 Sep 1;160(9):2049-2060. doi: 10.1210/en.2019-00367. Endocrinology. 2019. PMID: 31184711 Free PMC article.
-
MiRNA regulation of TRAIL expression exerts selective cytotoxicity to prostate carcinoma cells.Mol Cell Biochem. 2014 Mar;388(1-2):123-33. doi: 10.1007/s11010-013-1904-3. Epub 2013 Nov 30. Mol Cell Biochem. 2014. PMID: 24292881
-
Preparation and functional studies of hydroxyethyl chitosan nanoparticles loaded with anti-human death receptor 5 single-chain antibody.Onco Targets Ther. 2014 May 21;7:779-87. doi: 10.2147/OTT.S59872. eCollection 2014. Onco Targets Ther. 2014. PMID: 24899816 Free PMC article.
-
Autophagy in prostate cancer and androgen suppression therapy.Int J Mol Sci. 2013 Jun 6;14(6):12090-106. doi: 10.3390/ijms140612090. Int J Mol Sci. 2013. PMID: 23743823 Free PMC article. Review.
-
Combined Treatment of Androgen-Independent Prostate Cancer Cell Line DU145 with Chemotherapeutic Agents and Lithium Chloride: Effect on Growth Arrest and/or Apoptosis.Avicenna J Med Biotechnol. 2012 Apr;4(2):75-87. Avicenna J Med Biotechnol. 2012. PMID: 23408470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous